Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-07

Clinical Trial Update: Leptin in the Maintenance of Reduced Body Weight [Phase 2]

View source ↗

Summary

Phase 2 study evaluating leptin for maintaining reduced body weight in obesity. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leptin (leptin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2017-04-07